Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with PDT for AMD
NCT00043680Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Aug 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in age-related macular degeneration (AMD), sponsored by National Eye Institute. Started Aug 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00043680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043680.